Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Acta Physiologica Scandinavica

• Publication date

  1991-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1748-1716.1991.TB09236.XPMID 1722938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from l-arginine

  2004cited by this paper
• Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man.

  1992cited by this paper
• L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum.

  1991cited by this paper
• Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.

  1990cited by this paper
• Role of endothelium-formed nitric oxide on vascular responses.

  1990cited by this paper
• Nitric oxide. A novel signal transduction mechanism for transcellular communication.

  1990cited by this paper
• Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

  1990cited by this paper
• Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats

  1990cited by this paper
• Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

  1990cited by this paper
• Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

  1989cited by this paper
• Role of endothelium-derived nitric oxide in the regulation of blood pressure.

  1989cited by this paper
• Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.

  1989cited by this paper
• Principal mechanisms controlling penile retraction and protrusion in rabbits.

  1979cited by this paper

• Expression and activity of the umami taste receptor (TAS1R1/TAS1R3) in rat corpus cavernosum.

  2025cites this paper
• The bitter taste receptor (TAS2R) agonist denatonium promotes a strong relaxation of rat corpus cavernosum.

  2023cites this paper
• Erektile Dysfunktion als Folge des Diabetes mellitus

  2023cites this paper
• In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters.

  2022cites this paper
• Erektile Dysfunktion als Folge des Diabetes mellitus bei Männern

  2022cites this paper
• European Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model to Study Postradical Prostatectomy Erectile Dysfunction

  2020cites this paper
• Amiloride Relaxes Rat Corpus Cavernosum Relaxation In Vitro and Increases Intracavernous Pressure In Vivo.

  2019cites this paper
• EFFECTS OF MELATONIN ON NEURO– AND REPRODUCTIVE TOXICITIES INDUCED BY IN UTERO AND LACTATIONAL CO-EXPOSURE OF CHLORPYRIFOS AND CYPERMETHRIN IN MALE WISTAR RATS

  2018cites this paper
• Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome

  2017cites this paper
• Expression profiles of eNOS, iNOS and microRNA-27b in the corpus cavernosum of rats submitted to chronic alcoholism and Diabetes mellitus.

  2017cites this paper
• Potential pathways of pesticide action on erectile function – A contributory factor in male infertility

  2015cites this paper
• Chronic kidney disease and erectile dysfunction.

  2014cites this paper
• TOBACCO INDUCED PRIAPISM IN WISTER RAT: A CASE REPORT

  2013cites this paper
• Tobacco Induced Priapism in Wister Rat: A Case Report

  2013cites this paper
• Phosphodiesterase inhibitors in clinical urology

  2013cites this paper
• Inhibition of phosphodiesterase 4 enhances clitoral and vaginal blood flow responses to dorsal clitoral nerve stimulation or PGE1 in anesthetized female rats.

  2013cites this paper
• Amplified NO/cGMP‐mediated relaxation and ryanodine receptor‐to‐BKCa channel signalling in corpus cavernosum smooth muscle from phospholamban knockout mice

  2012cites this paper
• Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.

  2011cites this paper
• Phosphodiesterase 5 Inhibitors to Treat Erectile Dysfunction

  2010cites this paper
• Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus.

  2010cites this paper
• Pathophysiology of Erectile Dysfunction Following Radical Prostatectomy

  2009cites this paper
• Metrics for evaluation of age-related changes in erectile capacity in a rodent model.

  2009cites this paper
• Erectile dysfunction and lower urinary tract.

  2009cites this paper
• A Mutation in the Inner Mitochondrial Membrane Peptidase 2-Like Gene (Immp2l) Affects Mitochondrial Function and Impairs Fertility in Mice1

  2008cites this paper
• Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction.

  2008cites this paper
• Regulation of the nitric oxide pathway genes by tetrahydrofurandiols: microarray analysis of MCF-7 human breast cancer cells.

  2008cites this paper
• Pharmacotherapy for erectile dysfunction

  2008cites this paper
• Discovery of NO in the penis

  2008cites this paper
• The future of the oral pharmacotherapy of male erectile dysfunction: things to come

  2007cites this paper
• Effects of exercise training on the cardiovascular system: pharmacological approaches.

  2007cites this paper
• Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway.

  2007cites this paper
• Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve‐induced release of nitric oxide from the rabbit corpus cavernosum

  2007cites this paper
• Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction.

  2006cites this paper
• Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future.

  2006cites this paper
• Normal Anatomy and Physiology

  2006cites this paper
• Nitric oxide in the penis--science and therapeutic implications from erectile dysfunction to priapism.

  2006cites this paper
• Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part II)

  2005cites this paper
• Signal transduction in cavernous smooth muscle

  2005cites this paper
• Erectile dysfunction in mice lacking the large‐conductance calcium‐activated potassium (BK) channel

  2005influential citation
• Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction

  2005cites this paper
• Nerve-induced release of nitric oxide from the rabbit corpus cavernosum is modulated by cyclic guanosine 3',5'-monophosphate.

  2005cites this paper
• ORIGINAL RESEARCH—BASIC SCIENCE: Superoxide Anion Production in the Rat Penis Impairs Erectile Function in Diabetes: Influence of In Vivo Extracellular Superoxide Dismutase Gene Therapy

  2005cites this paper
• Nitric oxide and penile erectile function.

  2005cites this paper
• Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction

  2005cites this paper
• Endothelial nitric oxide synthase gene therapy for erectile dysfunction.

  2005cites this paper
• Endothelial function in patients with vasculogenic erectile dysfunction.

  2005cites this paper
• Physiology of penile erection and pathophysiology of erectile dysfunction.

  2005cites this paper
• Physiology and Pharmacology of Erectile Dysfunction

  2005cites this paper
• Pharmacology of Phosphodiesterase Inhibitors

  2005cites this paper
• Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part I)

  2005cites this paper
• Emerging oral drugs for erectile dysfunction

  2004cites this paper
• Therapeutic interventions targeting the nitric oxide system: current and potential uses in obstetrics, bone disease and erectile dysfunction.

  2004cites this paper
• Moderators’ introduction

  2004cites this paper
• Physiology of erectile function.

  2004cites this paper
• Vardenafil reverses erectile dysfunction induced by paroxetine in rats

  2003cites this paper
• Relaxation of rabbit corpus cavernosum by selective activators of voltage-gated sodium channels: role of nitric oxide-cyclic guanosine monophosphate pathway.

  2003cites this paper
• Sildenafil in erectile dysfunction: a critical review

  2003cites this paper
• Current and future trends in the oral pharmacotherapy of male erectile dysfunction

  2003cites this paper
• The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels

  2003cites this paper
• Enhanced relaxation of diabetic rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to erectile dysfunction

  2002cites this paper
• MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum

  2002cites this paper
• The Effect of The Specific Phosphodiesterase Type V Inhibitor, “Sildenafil Citrate”, on Alloxan-Induced Diabetic Rabbit Corpus Cavernosal Smooth Muscle

  2002cites this paper
• The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function

  2002cites this paper
• Molecular mechanisms for the regulation of penile smooth muscle contractility

  2002cites this paper
• Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction

  2002cites this paper
• Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection

  2002cites this paper
• Is there a common pathophysiology of erectile dysfunction and how does this relate to new pharmacotherapies?

  2002cites this paper
• Moderators 'i ntroduction

  2002cites this paper
• Potassium channels and erectile dysfunction.

  2002cites this paper
• UNIVERSIDADE DE SÃO PAULO

  2001cites this paper
• Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.

  2001cites this paper
• A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection

  2001cites this paper
• Differential effects of serotonin reuptake inhibitors on erectile responses, NO‐production, and neuronal NO synthase expression in rat corpus cavernosum tissue

  2001cites this paper
• Effects of sildenafil citrate, acetylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro.

  2001cites this paper
• The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

  2001cites this paper
• Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction

  2001cites this paper
• The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model.

  2001cites this paper
• Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases.

  2001cites this paper
• General use of animal models for investigation of the physiology of erection

  2001cites this paper
• The Effect of Aging and Exogenous Testosterone Replacement on Nitric Oxide Concentration and Activity of Nitric Oxide Synthase in the Rat Corpus Cavernosum

  2001cites this paper
• Morphological and functional in vitro and in vivo characterization of the mouse corpus cavernosum

  2001cites this paper
• Phosphodiesterase inhibitors in the treatment of erectile dysfunction.

  2000cites this paper
• Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration.

  2000cites this paper
• Chapter VIII The nitric oxide system in the urogenital tract

  2000cites this paper
• NO Effect on Penile Blood Flow and Lower Genitourinary Tract Function

  2000cites this paper
• The Molecular Basis of Penile Erection

  2000cites this paper
• Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice.

  2000cites this paper
• Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.

  2000cites this paper
• Effects of endothelial impairment by saponin on the responses to vasodilators and nitrergic nerve stimulation in isolated canine corpus cavernosum

  1999cites this paper
• The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats.

  1999cites this paper
• Erectile dysfunction and cardiovascular disease.

  1999cites this paper
• Evaluation of erectile response by continuous measurement of penile diameter in rats.

  1999cites this paper
• Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.

  1999cites this paper
• Selective nitrergic neurodegeneration in diabetes mellitus–a nitric oxide‐dependent phenomenon

  1999cites this paper
• Mitteilungen des Berufsverbandes Deutscher Internisten

  1999cites this paper
• Nitric oxide release in penile corpora cavernosa in a rat model of erection

  1999cites this paper
• Physiology and pathophysiology of erection: consequences for present medical therapy of erectile dysfunction

  1999cites this paper
• Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

  1999cites this paper
• The effects of diabetes on nitric oxide-mediated responses in rat corpus cavernosum.

  1999cites this paper
• Design and Evaluation of Nitrosylated α-Adrenergic Receptor Antagonists as Potential Agents for the Treatment of Impotence

  1999cites this paper